MetLife Investment Management’s Outset Medical OM Stock Holding History

MetLife Investment Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,074	Closed	-$156K	–	2856
2025 Q3	$156K	Hold	11,074	–	–	﹤0.01%	2449
2025 Q2	$213K	Buy	+11,074	New	+$173K	﹤0.01%	2155
2024 Q1	–	Sell	-1,807	Closed	-$147K	–	2814
2023 Q4	$147K	Hold	1,807	–	–	﹤0.01%	2405
2023 Q3	$295K	Hold	1,807	–	–	﹤0.01%	1967
2023 Q2	$593K	Buy	1,807 +69	+4%	+$21K	﹤0.01%	1584
2023 Q1	$480K	Hold	1,738	–	–	﹤0.01%	1675
2022 Q4	$673K	Hold	1,738	–	–	0.01%	1453
2022 Q3	$415K	Hold	1,738	–	–	﹤0.01%	1767
2022 Q2	$387K	Hold	1,738	–	–	﹤0.01%	1840
2022 Q1	$1.18M	Buy	1,738 +605	+53%	+$364K	0.01%	1223
2021 Q4	$783K	Hold	1,133	–	–	0.01%	1244
2021 Q3	$840K	Hold	1,133	–	–	0.01%	1214
2021 Q2	$849K	Buy	1,133 +824	+267%	+$630K	0.01%	1264
2021 Q1	$252K	Hold	309	–	–	﹤0.01%	1926
2020 Q4	$263K	Buy	+309	New	+$238K	﹤0.01%	1833

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

MetLife Investment Management's OM Position: Q4 2025 in Review

MetLife Investment Management sold out of Outset Medical (OM) in Q4 2025, closing a stake of 11,074 shares — an estimated $156K sold.

MetLife Investment Management first reported a position in OM in Q4 2020 and held it in 15 quarters. The position peaked at $1.18M in Q1 2022. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

MetLife Investment Management reported no remaining Outset Medical position as of Q4 2025 after selling out during the quarter.
MetLife Investment Management sold 11,074 Outset Medical shares in Q4 2025, an estimated $156K.
MetLife Investment Management first reported a position in Outset Medical in Q4 2020 and held it in 15 quarters.
MetLife Investment Management's Outset Medical position peaked at $1.18M in Q1 2022.
100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.